The Pulmonary Fibrosis Foundation (PFF), an advocacy group dedicated to advancing care for people with pulmonary fibrosis, has added two new members to its board of directors. Both new board members are physicians with extensive experience caring for people with pulmonary fibrosis, which causes scarring in the lungs,…
Discussion
Have you ever wondered what a columnist for Pulmonary Fibrosis News does while being hospitalized for 17 days? First, I focused on getting better. Second, I asked many questions of those caring for me. Finally, as I met other medical specialists, I asked them what they knew about…
Discussion
Celea Therapeutics received $180 million in financing to develop deupirfenidone (LYT-100), an investigational therapy that the company says has the potential to serve as a new standard of care for people with idiopathic pulmonary fibrosis (IPF). The funding will support the planned launch of SURPASS-IPF (NCT07284602), a…
Becoming educated and informed about PF is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your PF journey.
There is no cure for PF yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
